New study monitors Real-World impact of secukinumab on painful skin condition
NCT ID NCT07282015
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 142 Canadian adults with moderate-to-severe hidradenitis suppurativa who are prescribed secukinumab as part of their regular care. Researchers will track changes in disease severity over 12 months using a standard scoring system. The goal is to understand how well the treatment works in everyday practice and to monitor safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Novartis Investigative Site
RECRUITINGCalgary, Alberta, T2J 7E1, Canada
-
Novartis Investigative Site
RECRUITINGCalgary, Alberta, T3E 0B2, Canada
-
Novartis Investigative Site
RECRUITINGWinnipeg, Manitoba, R3M 3Z4, Canada
-
Novartis Investigative Site
RECRUITINGFredericton, New Brunswick, E3B 1G9, Canada
-
Novartis Investigative Site
RECRUITINGSt. John's, Newfoundland and Labrador, A1E 1V4, Canada
-
Novartis Investigative Site
RECRUITINGCobourg, Ontario, K9A 4J9, Canada
-
Novartis Investigative Site
RECRUITINGHamilton, Ontario, L8P4B4, Canada
-
Novartis Investigative Site
RECRUITINGLondon, Ontario, N6H 5L5, Canada
-
Novartis Investigative Site
RECRUITINGMarkham, Ontario, L3P 1X3, Canada
-
Novartis Investigative Site
RECRUITINGMississauga, Ontario, L4W 0C2, Canada
-
Novartis Investigative Site
RECRUITINGRichmond Hill, Ontario, L4C 9M7, Canada
-
Novartis Investigative Site
RECRUITINGToronto, Ontario, M4E 1R7, Canada
-
Novartis Investigative Site
RECRUITINGSaint-Jérôme, Quebec, J7Z 7E2, Canada
-
Novartis Investigative Site
RECRUITINGSherbrooke, Quebec, J1L 0H8, Canada
-
Novartis Investigative Site
RECRUITINGSaskatoon, Saskatchewan, S7N0N5, Canada